Join us for a discussion on the evolving gene therapy landscape, examined through the perspectives of regulators, pharmaceutical companies, investors, lawyers, and scientists. This webinar will explore how these stakeholder viewpoints intersect to shape innovation, commercialization, and risk in gene therapy, and what that means for protecting and advancing cutting-edge technologies. Attendees will gain practical insights into the legal, regulatory, and business considerations driving this rapidly advancing field.